As of 2023, actual data indicates that the mortality rate for ovary malignant neoplasms in Germany stood at 5.17 thousand female deaths. From 2024 onwards, projections show a slight decline, with the mortality rate decreasing from 5.13 in 2024 to 5.0 in 2028. This represents a gradual decrease by an average of 0.63% annually over the five-year period (CAGR).

Future trends to watch for include:

Advancements in early detection and treatment methods that might accelerate the reduction in mortality rates.
Impact of healthcare policies and funding in cancer research within Germany.
Potential influence of demographic changes, including age distribution and health behavior, on cancer mortality trends.